Monobodies as tool biologics for accelerating target validation and druggable site discovery
Author:
Affiliation:
1. Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA
2. Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY, USA
Abstract
Funder
National Cancer Institute
National Institute of Allergy and Infectious Diseases
American Cancer Society
Publisher
Royal Society of Chemistry (RSC)
Subject
Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biochemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2021/MD/D1MD00188D
Reference168 articles.
1. Drug discovery in academia: the third way?
2. Academic drug discovery: current status and prospects
3. 2018 FDA drug approvals
4. Trends in clinical success rates
5. How to improve R&D productivity: the pharmaceutical industry's grand challenge
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cytosolic delivery of monobodies using the bacterial type III secretion system inhibits oncogenic BCR::ABL1 signaling;2024-08-05
2. Methodological and regulatory aspects of pharmaceutical development of biological products;Pharmacy & Pharmacology;2024-01-29
3. Non-immunoglobulin synthetic binding proteins for oncology;Биохимия;2023-12-15
4. Non-Immunoglobulin Synthetic Binding Proteins for Oncology;Biochemistry (Moscow);2023-09
5. Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors;Proceedings of the National Academy of Sciences;2023-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3